B of A Securities Downgrades DH to Sell
B of A Securities has lowered its rating on DH to sell with a price target of $0.70, a 2.51% downside from the current price.
Key Points
- B of A Securities downgraded DH to a sell rating with a $0.70 target on June 29, 2026.
- B of A Securities's $0.70 price target implies 2.51% downside from Definitive Healthcare Corp.'s ($DH) current $0.72 share price.
- Shares of DH traded near $0.66 on Monday, reflecting the recent analyst action.
- Insiders at DH have been active, with several purchases and sales in early June.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
B of A Securities has downgraded its rating on DH to a sell, setting a price target of $0.70. The downgrade, announced on June 29, 2026, reflects a cautious outlook on the company's prospects.
B of A Securities vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in DH
In recent institutional moves, Advent International, L.P. maintained its position with 62.5 million shares valued at approximately $76.9 million. Goldman Sachs Group Inc increased its holdings by 101,949 shares, resulting in a total of about 6 million shares worth $7.4 million, marking a 1.7% increase. BlackRock, Inc. also grew its stake by 80,879 shares to hold nearly 3 million shares valued at $3.7 million, a 2.8% rise. Meanwhile, Dimensional Fund Advisors LP reduced its holdings by 251,434 shares, ending with about 1.7 million shares valued at $2 million, a 13.1% decrease.
Definitive Healthcare Corp. Stock Down 10.5%
Shares of DH traded near $0.66 on Monday. The stock has been under scrutiny following the recent analyst downgrade.
$DH price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Definitive Healthcare Corp.
Insider activity at DH has been notable. On June 4, 2026, Hamood Samuel, Kathleen Winters, Scott Stephenson, and Chilukuri Sastry each bought 189,190 shares. Earlier, on June 1, 2026, CEO Kevin Coop sold 66,050 shares at an average price of $0.99, while CFO Casey Heller sold 164,377 shares at the same price.
Analysts Set New Price Targets
On June 29, 2026, B of A Securities downgraded DH to a sell rating with a $0.70 price target. Barclays maintained its sell rating with a $1.00 target on March 30, 2026. Canaccord Genuity and Stephens & Co. have both maintained hold ratings with targets of $3.00 and $2.00, respectively, earlier in the year.
Bottom Line
The recent downgrade by B of A Securities to a sell rating with a $0.70 target adds pressure on DH, which is already trading at low levels. Investors will be watching closely to see how the company responds to these challenges. The activity of insiders and institutional investors provides additional context to the market's view on DH.
Get Definitive Healthcare Corp. alerts
New 13F filings, insider trades, and analyst moves on $DH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.